GLS2 and cancer: Moreover, the expression of combined GLS- and GLS2-centered- signature-gene set regulated clinical prognosis in certain cancers which further predict that the functional partners of GLS and GLS2 contribute to significant CNAs and mutations and subsequently regulate the clinical outcomes in cancers.